Jaccoud arthropathy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Jaccoud arthropathy | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Joint pain, joint swelling, joint deformity |
| Complications | Joint instability, functional impairment |
| Onset | Gradual |
| Duration | Chronic |
| Types | N/A |
| Causes | Systemic lupus erythematosus, rheumatic fever, scleroderma, Sjogren's syndrome |
| Risks | History of rheumatic fever, autoimmune diseases |
| Diagnosis | Clinical examination, X-ray, MRI |
| Differential diagnosis | Rheumatoid arthritis, osteoarthritis, psoriatic arthritis |
| Prevention | N/A |
| Treatment | Nonsteroidal anti-inflammatory drugs, physical therapy, disease-modifying antirheumatic drugs |
| Medication | N/A |
| Prognosis | Variable, depends on underlying condition |
| Frequency | Rare |
| Deaths | N/A |
Jaccoud's Arthropathy (JA) is a chronic, non-erosive rheumatoid-like deformity, primarily affecting the hands and feet, without the same degree of joint destruction associated with rheumatoid arthritis. It is named after the French physician François Sigismond Jaccoud, who first described the condition in the 19th century. JA is often associated with systemic diseases, most notably systemic lupus erythematosus (SLE), but it can also be seen in association with other conditions such as rheumatic fever, scleroderma, and dermatomyositis.
Etiology and Pathogenesis[edit]
The exact cause of Jaccoud's Arthropathy is not fully understood, but it is believed to be related to chronic inflammation leading to ligamentous laxity and subsequent joint deformity. Unlike rheumatoid arthritis, JA does not typically result in joint erosion or significant bone damage. The association with systemic autoimmune diseases suggests an underlying immune-mediated mechanism.
Clinical Features[edit]
Patients with Jaccoud's Arthropathy typically present with a history of a systemic inflammatory condition. The hallmark of JA is the presence of reversible joint deformities, such as ulnar deviation of the fingers, swan-neck deformities, and thumb subluxation, without significant erosive damage on radiographic imaging. These deformities are often less severe and more correctable compared to those seen in rheumatoid arthritis. Other symptoms may include joint pain, swelling, and reduced range of motion.
Diagnosis[edit]
The diagnosis of Jaccoud's Arthropathy is primarily clinical, based on the characteristic deformities and the history of an associated systemic disease. Laboratory tests may show markers of inflammation and autoimmunity, depending on the underlying condition. Imaging studies, particularly X-rays, are crucial for demonstrating the absence of erosive damage typical of other arthritides and may show soft tissue swelling or joint space narrowing.
Treatment[edit]
Management of Jaccoud's Arthropathy focuses on controlling the underlying systemic disease and managing symptoms. This may involve the use of anti-inflammatory medications, immunosuppressants, or biologic agents, depending on the associated condition. Physical therapy plays a key role in maintaining joint function and preventing deformity progression. In some cases, orthopedic interventions may be necessary to correct deformities.
Prognosis[edit]
The prognosis of Jaccoud's Arthropathy varies depending on the underlying systemic disease and the effectiveness of its management. While the joint deformities themselves can often be managed with conservative measures, the overall outcome is closely tied to the control of the systemic condition.
Epidemiology[edit]
Jaccoud's Arthropathy is a rare condition, and its exact prevalence is difficult to determine. It is more commonly seen in patients with systemic lupus erythematosus but can occur in association with other systemic inflammatory diseases.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

